WHEN SHOULD PROSTATE CANCER TUMOR SEQUENCING PROMPT CONSIDERATION FOR GERMLINE TESTING?

被引：0
|
作者：
Hong Truong
Breen, Kelsey
Kemel, Yelena
Lenis, Andrew
Reisz, Peter
Benfante, Nicole
Ehdaie, Behfar
Touijer, Karim
Laudone, Vincent
Eastham, James
Joseph, Vijai
Birsoy, Ozge
Mandelker, Diana
Stadler, Zsofia
Offit, Kenneth
Morris, Michael
Abida, Wassim
Robson, Mark
Carlo, Maria
机构：
来源：
JOURNAL OF UROLOGY | 2021年 / 206卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD44-01
引用
收藏
页码：E736 / E736
页数：1
相关论文
共 50 条
  • [1] Characterization of findings on prostate cancer tumor sequencing that should prompt consideration for germline testing.
    Truong, Hong
    Breen, Kelsey
    Kemel, Yelena
    Lenis, Andrew Thomas
    Reisz, Peter
    Benfante, Nicole
    Ehdaie, Behfar
    Touijer, Karim A.
    Laudone, Vincent Paul
    Scardino, Peter T.
    Eastham, James Andrew
    Joseph, Vijai
    Birsoy, Ozge
    Mandelker, Diana
    Stadler, Zsofia Kinga
    Offit, Kenneth
    Morris, Michael J.
    Abida, Wassim
    Robson, Mark E.
    Carlo, Maria Isabel
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] When Should Tumor Genomic Profiling Prompt Consideration of Germline Testing?
    DeLeonardis, Kim
    Hogan, Lauren
    Cannistra, Stephen A.
    Rangachari, Deepa
    Tung, Nadine
    JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (09) : 465 - +
  • [3] Prostate Cancer Genomic Testing: When Sequencing Is Not Sufficient and Germline Testing Is Necessary
    Jacobs, Michelle F.
    Greenberg, Samantha E.
    EUROPEAN UROLOGY, 2023, 83 (01) : 39 - 40
  • [4] Germline Testing in Prostate Cancer: When and Who to Test
    Sokolova, Alexandra O.
    Cheng, Heather H.
    ONCOLOGY-NEW YORK, 2021, 35 (10): : 645 - 653
  • [5] When to Use Germline Genetic Testing in Prostate Cancer
    Giri, Veda N.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (02) : 78 - 81
  • [6] Frequency of germline testing after tumor sequencing by cancer type
    Karpel, H. C.
    Pothuri, B.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S597 - S597
  • [7] Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer
    Truong, Hong
    Breen, Kelsey
    Nandakumar, Subhiksha
    Sjoberg, Daniel D.
    Kemel, Yelena
    Mehta, Nikita
    Lenis, Andrew T.
    Reisz, Peter A.
    Carruthers, Jessica
    Benfante, Nicole
    Joseph, Vijai
    Khurram, Aliya
    Gopalan, Anuradha
    Fine, Samson W.
    Reuter, Victor E.
    Vickers, Andrew J.
    Birsoy, Ozge
    Liu, Ying
    Walsh, Michael
    Latham, Alicia
    Stadler, Zsofia K.
    Pietzak, Eugene
    Ehdaie, Behfar
    Touijer, Karim A.
    Laudone, Vincent P.
    Slovin, Susan F.
    Autio, Karen A.
    Danila, Daniel C.
    Rathkopf, Dana E.
    Eastham, James A.
    Chen, Yu
    Morris, Michael J.
    Offit, Kenneth
    Solit, David B.
    Scher, Howard I.
    Abida, Wassim
    Robson, Mark E.
    Carlo, Maria I.
    EUROPEAN UROLOGY, 2023, 83 (01) : 29 - 38
  • [8] Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate Cancer
    Berchuck, Jacob E.
    Boiarsky, Daniel
    Silver, Rebecca
    Sunkara, Rajitha
    McClure, Heather M.
    Tsai, Harrison K.
    Siegmund, Stephanie
    Tewari, Alok K.
    Nowak, Jonathan A.
    Lindeman, Neal I.
    Rana, Huma Q.
    Choudhury, Atish D.
    Pomerantz, Mark M.
    Freedman, Matthew L.
    Van Allen, Eliezer M.
    Taplin, Mary-Ellen
    JCO PRECISION ONCOLOGY, 2022, 6
  • [9] Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer
    Lincoln, Stephen E.
    Nussbaum, Robert L.
    Kurian, Allison W.
    Nielsen, Sarah M.
    Das, Kingshuk
    Michalski, Scott
    Yang, Shan
    Ngo, Nhu
    Blanco, Amie
    Esplin, Edward D.
    JAMA NETWORK OPEN, 2020, 3 (10)
  • [10] When to Use Somatic Tumor Testing in Prostate Cancer
    Friedlander, Terence W.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (08) : 487 - 489
12345